Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015058324> ?p ?o ?g. }
- W3015058324 abstract "Abstract Background To determine whether radiomics features based on contrast-enhanced CT (CECT) can preoperatively predict lymphovascular invasion (LVI) and clinical outcome in gastric cancer (GC) patients. Methods In total, 160 surgically resected patients were retrospectively analyzed, and seven predictive models were constructed. Three radiomics predictive models were built from radiomics features based on arterial (A), venous (V) and combination of two phase (A + V) images. Then, three Radscores (A-Radscore, V-Radscore and A + V-Radscore) were obtained. Another four predictive models were constructed by the three Radscores and clinical risk factors through multivariate logistic regression. A nomogram was developed to predict LVI by incorporating A + V-Radscore and clinical risk factors. Kaplan-Meier curve and log-rank test were utilized to analyze the outcome of LVI. Results Radiomics related to tumor size and intratumoral inhomogeneity were the top-ranked LVI predicting features. The related Radscores showed significant differences according to LVI status ( P < 0.01). Univariate logistic analysis identified three clinical features (T stage, N stage and AJCC stage) and three Radscores as LVI predictive factors. The Clinical-Radscore (namely, A + V + C) model that used all these factors showed a higher performance (AUC = 0.856) than the clinical (namely, C, including T stage, N stage and AJCC stage) model (AUC = 0.810) and the A + V-Radscore model (AUC = 0.795) in the train cohort. For patients without LVI and with LVI, the median progression-free survival (PFS) was 11.5 and 8.0 months ( P < 0.001),and the median OS was 20.2 and 17.0 months ( P = 0.3), respectively. In the Clinical-Radscore-predicted LVI absent and LVI present groups, the median PFS was 11.0 and 8.0 months ( P = 0.03), and the median OS was 20.0 and 18.0 months ( P = 0.05), respectively. N stage, LVI status and Clinical-Radscore-predicted LVI status were associated with disease-specific recurrence or mortality. Conclusions Radiomics features based on CECT may serve as potential markers to successfully predict LVI and PFS, but no evidence was found that these features were related to OS. Considering that it is a single central study, multi-center validation studies will be required in the future to verify its clinical feasibility." @default.
- W3015058324 created "2020-04-10" @default.
- W3015058324 creator A5021725931 @default.
- W3015058324 creator A5025255532 @default.
- W3015058324 creator A5043202304 @default.
- W3015058324 creator A5047424161 @default.
- W3015058324 creator A5057105971 @default.
- W3015058324 creator A5071889369 @default.
- W3015058324 creator A5089188165 @default.
- W3015058324 date "2020-04-05" @default.
- W3015058324 modified "2023-10-09" @default.
- W3015058324 title "Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary study" @default.
- W3015058324 cites W1222616959 @default.
- W3015058324 cites W1538897626 @default.
- W3015058324 cites W2009441994 @default.
- W3015058324 cites W2017941985 @default.
- W3015058324 cites W2137595517 @default.
- W3015058324 cites W2147821156 @default.
- W3015058324 cites W2180029390 @default.
- W3015058324 cites W2272715130 @default.
- W3015058324 cites W2272984102 @default.
- W3015058324 cites W2346343836 @default.
- W3015058324 cites W2552356122 @default.
- W3015058324 cites W2560939597 @default.
- W3015058324 cites W2628914529 @default.
- W3015058324 cites W2751632396 @default.
- W3015058324 cites W2792405608 @default.
- W3015058324 cites W2795247859 @default.
- W3015058324 cites W2804972379 @default.
- W3015058324 cites W2889586091 @default.
- W3015058324 cites W2889646458 @default.
- W3015058324 cites W2903047250 @default.
- W3015058324 cites W2903902166 @default.
- W3015058324 cites W2921899076 @default.
- W3015058324 cites W2922010156 @default.
- W3015058324 cites W2937706921 @default.
- W3015058324 cites W2939014135 @default.
- W3015058324 cites W2947019990 @default.
- W3015058324 cites W2951465618 @default.
- W3015058324 cites W2982667967 @default.
- W3015058324 cites W309913469 @default.
- W3015058324 cites W4211130279 @default.
- W3015058324 doi "https://doi.org/10.1186/s40644-020-00302-5" @default.
- W3015058324 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7132895" @default.
- W3015058324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32248822" @default.
- W3015058324 hasPublicationYear "2020" @default.
- W3015058324 type Work @default.
- W3015058324 sameAs 3015058324 @default.
- W3015058324 citedByCount "38" @default.
- W3015058324 countsByYear W30150583242021 @default.
- W3015058324 countsByYear W30150583242022 @default.
- W3015058324 countsByYear W30150583242023 @default.
- W3015058324 crossrefType "journal-article" @default.
- W3015058324 hasAuthorship W3015058324A5021725931 @default.
- W3015058324 hasAuthorship W3015058324A5025255532 @default.
- W3015058324 hasAuthorship W3015058324A5043202304 @default.
- W3015058324 hasAuthorship W3015058324A5047424161 @default.
- W3015058324 hasAuthorship W3015058324A5057105971 @default.
- W3015058324 hasAuthorship W3015058324A5071889369 @default.
- W3015058324 hasAuthorship W3015058324A5089188165 @default.
- W3015058324 hasBestOaLocation W30150583241 @default.
- W3015058324 hasConcept C105795698 @default.
- W3015058324 hasConcept C121608353 @default.
- W3015058324 hasConcept C126322002 @default.
- W3015058324 hasConcept C126838900 @default.
- W3015058324 hasConcept C143998085 @default.
- W3015058324 hasConcept C144301174 @default.
- W3015058324 hasConcept C146357865 @default.
- W3015058324 hasConcept C151730666 @default.
- W3015058324 hasConcept C151956035 @default.
- W3015058324 hasConcept C161584116 @default.
- W3015058324 hasConcept C199163554 @default.
- W3015058324 hasConcept C2778559731 @default.
- W3015058324 hasConcept C2778740770 @default.
- W3015058324 hasConcept C2779013556 @default.
- W3015058324 hasConcept C2780091936 @default.
- W3015058324 hasConcept C2989005 @default.
- W3015058324 hasConcept C33923547 @default.
- W3015058324 hasConcept C34626388 @default.
- W3015058324 hasConcept C38180746 @default.
- W3015058324 hasConcept C71924100 @default.
- W3015058324 hasConcept C86803240 @default.
- W3015058324 hasConceptScore W3015058324C105795698 @default.
- W3015058324 hasConceptScore W3015058324C121608353 @default.
- W3015058324 hasConceptScore W3015058324C126322002 @default.
- W3015058324 hasConceptScore W3015058324C126838900 @default.
- W3015058324 hasConceptScore W3015058324C143998085 @default.
- W3015058324 hasConceptScore W3015058324C144301174 @default.
- W3015058324 hasConceptScore W3015058324C146357865 @default.
- W3015058324 hasConceptScore W3015058324C151730666 @default.
- W3015058324 hasConceptScore W3015058324C151956035 @default.
- W3015058324 hasConceptScore W3015058324C161584116 @default.
- W3015058324 hasConceptScore W3015058324C199163554 @default.
- W3015058324 hasConceptScore W3015058324C2778559731 @default.
- W3015058324 hasConceptScore W3015058324C2778740770 @default.
- W3015058324 hasConceptScore W3015058324C2779013556 @default.
- W3015058324 hasConceptScore W3015058324C2780091936 @default.
- W3015058324 hasConceptScore W3015058324C2989005 @default.
- W3015058324 hasConceptScore W3015058324C33923547 @default.
- W3015058324 hasConceptScore W3015058324C34626388 @default.